What this means
This study will test a repair device for weak spots in the body's main artery. It will also check how frailty affects results and how well patients recover. It has not reported results yet, so it cannot tell us if the device works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including California
The science
- Registered title
- Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
- Trial ID
- NCT04524247 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Thoracoabdominal Aortic Aneurysm, Thoracoabdominal; Aortic, Aneurysm, Dissecting, Pararenal Aneurysm, Frailty Syndrome
- What is tested
- Physician Modified Endografts
- Sponsor
- University of Southern California
- Ages
- 18 Years to no maximum
- Dates
- First posted Aug 24, 2020 · updated Jul 1, 2024
Registry summary
The primary objective of this single arm, prospective feasibility study, Impact of Frailty on Clinical Outcomes of Patients Treated for Thoracoabdominal and Complex Abdominal Aortic Aneurysms with Physician-Modified Fenestrated and Branched Stent Grafts, is to assess the use of the physician-modified fenestrated/branched endografts to repair thoracoabdominal and complex aortic aneurysms in subjects having appropriate anatomy, at high risks for open repairs. The primary intent of the study is to assess safety and preliminary effectiveness of the device acutely (i.e., treatment success and technical success), at 30 days (i.e., the rate of major adverse events (MAE)) and at 3 months, 6 months, 12 months, and annually to 5 years (i.e., the proportion of treatment group subjects that achieve and maintain treatment success).
Additionally, this study will assess the degree of patient frailty before and after the aneurysm repair, as well as the association between the preoperative baseline frailty and clinical outcomes detailed above. This will help improve subject selection in identification of high risk patients who would not only suffer poor clinical outcomes, but also experience decline in their functional status.
Sites (1)
- Keck Hospital of University of Southern California, Los Angeles, California, United States
